Skip to main content
Log in

β-Funaltrexamine Inhibits Inducible Nitric-oxide Synthase Expression in Human Astroglial Cells

  • Brief Report
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

The inducible isoform of nitric-oxide synthase (iNOS) is involved in neuropathogenesis associated with infection and disease in the brain. Hence, there is considerable interest in the identification of therapeutic interventions to prevent iNOS-mediated pathology. Astroglia are a major site of iNOS expression during neuropathogenesis. To mimic a key component of neuroinflammation, human A172 astroglial cells were exposed in vitro to a cytokine mixture containing interferon γ, tumor necrosis factor α, and interleukin-1β, resulting in significant iNOS expression. Next, we assessed the effects of the mu opioid receptor antagonist, β-funaltrexamine (β-FNA), on cytokine induced iNOS expression in human astroglia. β-FNA dose-dependently inhibited iNOS expression. β-FNA transcriptionally (or pre-transcriptionally) inhibited cytokine-induced iNOS activation as indicated by a significant decrease in NOS2 messenger RNA expression. Further characterization of the novel, anti-inflammatory actions of β-FNA may provide insights for pharmacologic strategies to treat or prevent brain pathologies associated with neuroinflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  • Davis RL, Syapin PJ (2004) Acute ethanol exposure modulates expression of inducible nitric-oxide synthase in human astroglia: evidence for a transcriptional mechanism. Alcohol 32:195–202

    Article  PubMed  CAS  Google Scholar 

  • Davis RL, Dertien J, Syapin PJ (2002) Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells. Alcohol Clin Exp Res 26:1404–1411

    PubMed  CAS  Google Scholar 

  • Davis RL, Buck DJ, Saffarian N, Stevens CW (2007) The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells. J Neuroimmunol 186:141–149

    Article  PubMed  CAS  Google Scholar 

  • Hettinger AM, Allen MR, Zhang BR, Goad DW, Malayer JR, Geisert RD (2001) Presence of the acute phase protein, bikunin, in the endometrium of gilts during estrous cycle and early pregnancy. Biol Reprod 65:507–513

    Article  PubMed  CAS  Google Scholar 

  • Jafarian-Tehrani M, Louin G, Royo NC, Besson VC, Bohme GA, Plotkine M, Marchand-Verrecchia C (2005) 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Nitric Oxide 12:61–69

    Article  PubMed  CAS  Google Scholar 

  • Lee J, Kim MS, Park C, Jung EB, Choi DH, Kim TY, Moon SK, Park R (2004) Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol Immunotoxicol 26:17–28

    Article  PubMed  CAS  Google Scholar 

  • Liu B, Du L, Hong JS (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607–617

    PubMed  CAS  Google Scholar 

  • Liu Y, Qin L, Wilson BC, An L, Hong JS, Liu B (2002) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1–42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J Pharmacol Exp Ther 302:1212–1219

    Article  PubMed  CAS  Google Scholar 

  • Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M (2006) Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50:182–190

    Article  PubMed  CAS  Google Scholar 

  • Marchetti B, Serra PA, Tirolo C, L’Episcopo F, Caniglia S, Gennuso F, Testa N, Miele E, Desole S, Barden N, Morale MC (2005) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Res Brain Res Rev 48:302–321

    Article  PubMed  CAS  Google Scholar 

  • Poluektova L, Meyer V, Walters L, Paez X, Gendelman HE (2005) Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis. Glia 52:344–353

    Article  PubMed  Google Scholar 

  • Qi JA, Heyman JS, Sheldon RJ, Koslo RJ, Porreca F (1990) Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. J Pharmacol Exp Ther 252:1006–1011

    PubMed  CAS  Google Scholar 

  • Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 34:209–220

    Article  PubMed  CAS  Google Scholar 

  • Zhao H, Huang HW, Wu GC, Cao XD (2002) Effect of orphanin FQ on interleukin-1beta mRNA transcripts in the rat CNS. Neuroscience 114:1019–1031

    PubMed  CAS  Google Scholar 

  • Zhao P, Huang Y, Zuo Z (2006) Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65:945–952

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported in part by NIH grants AA 014955 (RLD) and DA 012448 (CWS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Randall L. Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R.L., Buck, D.J., Saffarian, N. et al. β-Funaltrexamine Inhibits Inducible Nitric-oxide Synthase Expression in Human Astroglial Cells. J Neuroimmune Pharmacol 3, 150–153 (2008). https://doi.org/10.1007/s11481-008-9102-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-008-9102-x

Keywords

Navigation